Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 5Rectal Neoplasms 3Ovarian Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Gastrointestinal Stromal Tumors 2Surgical Wound Infection 1Peritoneal Neoplasms 1Neoplasm Metastasis 1Malignant Neoplasm of Transverse Colon 1Lung Neoplasms 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Genital Neoplasms, Female 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Diverticulum 1Colonic Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 2anlotinib 2Pemetrexed 2Paclitaxel 2Bevacizumab 2relacorilant 1olaparib 1niraparib 1nilotinib 1lenvatinib 1Therapeutic Touch 1Radiotherapy 1Ocoxin 1Nivolumab 1Laparoscopy 1Ipilimumab 1Filgrastim 1Electrocardiography 1Darbepoetin alfa 1Carboplatin 1CP protocol 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Genital Neoplasms, Female × Laparoscopy × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡